ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Animal models"

  • Abstract Number: 438 • 2012 ACR/ARHP Annual Meeting

    Methyl Supplementation of Rheumatoid Arthritis Synovial Fibroblasts Regulates the Expression of Transcription Factors and Matrix Metalloproteinases

    Edvardas Bagdonas1, Emmanuel Karouzakis2, Astrid Jungel2, Caroline Ospelt1, Renate E. Gay1, Steffen Gay1, Beat A. Michel1 and Michel Neidhart1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland

    Background/Purpose: Previously we reported that methyl supplementation can reverse the global hypomethylation of rheumatoid arthritis synovial fibroblasts (RASF) and attenuate their aggressive behaviour. Now we…
  • Abstract Number: 2680 • 2012 ACR/ARHP Annual Meeting

    Soluble Receptor for Advanced Glycation End Products Alleviates Nephritis in NZB/WF1 Mice

    Sang-Won Lee1, Kyu-Hyoung Park1, Sungha Park2, Ji-Hye Kim1, Sung-You Hong2, Soo Kon Lee3, Donghoon Choi2 and Yong-Beom Park4, 1Internal Medicine, Yonse University College of Medicine, Seoul, South Korea, 2Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, 3Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

    Background/Purpose: The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor that interacts with multiple ligands such as high mobility group box 1…
  • Abstract Number: 2523 • 2012 ACR/ARHP Annual Meeting

    Periodontal Pathogens Directly Promote Autoimmune Experimental Arthritis by Inducing a Toll-Like Receptor 2 and Interleukin-1 Driven Th17 Response

    Shahla Abdollahi-Roodsaz1, Sabrina Garcia de Aquino2, Marije I. Koenders3, Fons A. van de Loo4, Ger J. Pruijn5, Mario J. Avila Campos6, Fernando Q. Cunha7, Joni A. Cirelli2 and Wim B. van den Berg1, 1Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Department of Diagnosis and Oral Surgery, Periodontic Division, Araraquara Dental School, Sao Paolo, Brazil, 3Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, 4Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 5Department of Biomolecular Chemistry, Radboud University, Nijmegen, Netherlands, 6Department of Microbiology, Institute of Biomedical Sciences—ICB/USP, Sao Paulo, Brazil, 7Department of Pharmacology, School of Medicine of Ribeirao Preto, Sao Paolo, Brazil

    Background/Purpose: The periodontal pathogen Porphyromonas gingivalishas been associated with the pathogenesis of rheumatoid arthritis (RA) because of its ability to citrullinate mammalian proteins and to…
  • Abstract Number: 2072 • 2012 ACR/ARHP Annual Meeting

    Bone Formation and Resorption Are Both Increased in Autoimmune Arthritis

    Kresten K. Keller1, Jesper Skovhus Thomsen2, Kristian Stengaard-Pedersen1, Frederik Dagnæs-Hansen3, Jens R. Nyengaard4 and Ellen-Margrethe Hauge1, 1Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 2Institute of Anatomy, Aarhus University, 3Institute of Medical Microbiology and Immunology, Aarhus University, Aarhus, Denmark, 4Stereology and Electron Microscopy Laboratory, Centre for Stochastic Geometry and Advanced Bioimaging. Aarhus University hospital, Aarhus, Denmark

    Background/Purpose: Bone destruction in the joints of patients with rheumatoid arthritis (RA) is the result of a combination of osteoclastic bone resorption and osteoblastic bone…
  • Abstract Number: 1076 • 2012 ACR/ARHP Annual Meeting

    FLIP in Dendritic Cells May Regulate Hematopoietic Homeostasis and Modulating Inflammation and Immunity

    Qi Quan Huang1, Robert Birkett2, Harris R. Perlman3 and Richard M. Pope4, 1Medicine/Rheumatology, Northwestern University, Chicago, IL, 2Division of Rheumatology, Department od Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Feinberg School of Medicine, Northwestern University, Chicago, IL, 4Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

    Background/Purpose: We previously demonstrated that FLIP in myeloid linage cells is necessary for neutrophil homeostasis and macrophage differentiation.  Therefore studies were performed to determine the…
  • Abstract Number: 331 • 2012 ACR/ARHP Annual Meeting

    PDL241, a Novel Humanized Monoclonal Antibody, Reveals CD319 As a Therapeutic Target for Rheumatoid Arthritis

    Michel P.M. Vierboom1, Jacky Woo2, Hakju Kwon2, Debra Chao2, Shiming Ye2, Jianmin Li2, Karen Lin2, Irene Tang2, Nicole Belmar2, Taymar Hartman2, Elia Breedveld1, Bert A. ‘t Hart1 and Gary C. Starling2, 1Department of Immunobiology, Biomedical Primate Research Centre, Rijswijk, Netherlands, 2Abbott Biotherapeutics, Redwood City, CA

    Background/Purpose: Current therapies have shown tremendous progress in the treatment of rheumatoïd arthritis (RA). However, a substantial group of RA patients are still refractory to…
  • Abstract Number: 2681 • 2012 ACR/ARHP Annual Meeting

    Blocking the Serum Protease Inhibitor Activity of Plasminogen Activator Inhibitor-1 Protects Mice From Development of Glomerulonephritis in a Model of Lupus Nephritis

    Brian Naiman1, Tracy Delaney1, Lily Cheng2, Philip Brohawn2, Chris Morehouse2, Christopher Groves1, Isabelle de-Mendez3, Dominic Corkill4, Anthony Coyle5, Ronald Herbst1 and Jane Connor1, 1Respiration, Inflammation and Autoimmunity, MedImmune, LLC, Gaithersburg, MD, 2Translational Sciences, MedImmune, LLC, Gaithersburg, MD, 3Research, MedImmune, LLC, Cambridge, United Kingdom, 4Respiration, Inflammation and Autoimmunity, MedImmune, LLC, Cambridge, United Kingdom, 5Centers for Therapeutic Innovation, Pfizer, Inc. (formerly MedImmune LLC, Gaithersburg, MD, USA), Cambridge, MA

    Background/Purpose: Lupus nephritis is an autoimmune disorder which is characterized by extracellular matrix accumulation driven by immune complex deposition and in which thrombosis and sclerosis…
  • Abstract Number: 2327 • 2012 ACR/ARHP Annual Meeting

    CGEN-15001, a Novel Negative Costimulatory Fusion Protein Is Effective in the Collagen-Induced Arthritis Mouse Model of Rheumatoid Arthritis

    Iris Hecht1, Kay McNamee2, Ilan Vaknin3, Anat Oren3, Joseph R. Podojil4, Galit Rotman3, Eyal Neria3, Stephen D. Miller4 and Richard O. Williams2, 1R&D, Compugen Ltd., Tel Aviv, Israel, 2Kennedy Institute of Rheumatology, Oxford University, Oxford, United Kingdom, 3Compugen Ltd., Tel Aviv, Israel, 4Microbiology-Immunology, Northwestern University, Chicago, IL

    Background/Purpose: CGEN-15001 is a recombinant Fc fusion protein consisting of the extracellular domain of CGEN-15001T, a protein predicted to be a member of the B7/CD28…
  • Abstract Number: 2078 • 2012 ACR/ARHP Annual Meeting

    Low-Density Lipoprotein Receptor Deficiency Ameliorates the Development of Inflammatory Arthritis

    Shawn Rose1 and Harris R. Perlman2, 1Department of Medicine, Division of Rheumatology, Northwestern University, Chicago, IL, 2Feinberg School of Medicine, Northwestern University, Chicago, IL

    Background/Purpose: Patients with rheumatoid arthritis (RA) carry a higher risk of cardiovascular disease compared to the general population.  The low-density lipoprotein receptor (LDLR) and Apolipoprotein…
  • Abstract Number: 1056 • 2012 ACR/ARHP Annual Meeting

    Fc Receptor Gamma-Dependent Autoimmune Endocarditis in K/BxN Mice

    Patricia M. Hobday1, Jennifer L. Auger2, J. Sjef Verbeek3, Jeffrey V. Ravetch4 and Bryce A. Binstadt2, 1Department of Pediatrics, Division of Pediatric Rheumatology, University of Minnesota, Minneapolis, MN, 2Center for Immunology and Department of Pediatrics, University of Minnesota, Minneapolis, MN, 3Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands, 4The Rockefeller University, New York, NY

    Background/Purpose: Arthritis and endocarditis co-exist in several human rheumatic diseases, including systemic lupus erythematosus, rheumatic fever, and rheumatoid arthritis.  K/BxN TCR transgenic mice, well known…
  • Abstract Number: 332 • 2012 ACR/ARHP Annual Meeting

    Blockade of CTGF Restores Aberrant Ostoclastgenesis in Collagen Induced Arthritis (CIA) Mice Through Inhibition of Th-17 Differentiation

    Kazuhisa Nozawa1, Maki Fujishiro2, Ayako Yamaguchi1, Mikiko Kawasaki2, Shouzou Ichinose2, Mitsuaki Yanagida2, Kazuhisa Iwabuchi2, Keigo Ikeda3, Shinji Morimoto4, Megumi Morioka5, Yoshinari Takasaki6 and Iwao Sekigawa3, 1Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 2Institute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan, 3Internal Medicine 2, Juntendo University Urayasu Hospital, Tomioka, Urayasu, Chiba, Japan, 4Juntendo University Urayasu Hospital, Tokyo, Japan, 5Nihon Nosan Corporation, Nihon Nosan Corporation, Kanagawa, Japan, 6Internal Medicine and Rheumatology,, Juntendo University School of Medicine, Tokyo, Japan

    Background/Purpose: Our previous study demonstrated changes in the profiles of serum protein biomarkers in infliximab-treated rheumatoid arthritis (RA) patients using a novel approach to proteomic…
  • Abstract Number: 2682 • 2012 ACR/ARHP Annual Meeting

    Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Systemic Lupus Erythematosus

    Tomohiro Koga1, Kunihiro Ichinose2, Masayuki Mizui3, José C. Crispín4 and George C. Tsokos4, 1Medicine/Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Department of Immunology and Rheumatology, Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 3Division of Rheumatology, Department of Medicine,, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 4Medicine/Rheumatology, BIDMC, Harvard Medical School, Boston, MA

    Background/Purpose: T cells from patients with SLE exhibit abnormal signaling upon TCR engagement and have an altered gene expression profile. Accordingly, the regulation of several transcription factors…
  • Abstract Number: 2306 • 2012 ACR/ARHP Annual Meeting

    Intratracheal Instillation of Omniscan in an Adenine-Induced Model of Chronic Renal Failure: A New Model of Nephrogenic Systemic Fibrosis

    Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Nephrogenic Systemic Fibrosis (NSF), a generalized progressive fibrotic disorder, occurs in some patients with renal insufficiency exposed to various gadolinium based contrast agents (GdBCA). …
  • Abstract Number: 2080 • 2012 ACR/ARHP Annual Meeting

    IL-20 Is Not Involved in Mouse Collagen Induced Arthritis

    Christina Andersson1, Kyle Serikawa2, Hermann Pelzer3, Peter Thygesen3, Patricia Smith2, Kim Kruse2, Shameek Biswas2, Brian Fox2, Anders Milner4, Peter Kvist5, Josephine Hebsgaard6, Jesper Pass7 and John Rømer8, 1AID Models, Immunopharmacology, Biopharmaceutical Research Unit, Novo Nordisk A/S, Måløv, Denmark, 2Molecular Immunology, Biopharmaceutical Research Unit, Novo Nordisk A/S, Seattle, WA, 3Exploratory ADME, Biopharmaceutical Research Unit, Novo Nordisk A/S, Måløv, Denmark, 4DMPK, Cell and Antibody Analysis, Biopharmaceutical Research Unit, Novo Nordisk A/S, Måløv, Denmark, 5Histology, Novo Nordisk A/S, Måløv, Denmark, 6Histology, Biopharmaceutical Research Unit, Novo Nordisk A/S, Måløv, Denmark, 7Antibody Thechnology, Biopharmaceutical Research Unit, Novo Nordisk A/S, Måløv, Denmark, 8Inflammation Science, Biopharmaceutical Research Unit, Novo Nordisk A/S, Måløv, Denmark

    Background/Purpose: Interleukin-20 (IL-20) is a pro-inflammatory cytokine involved in the pathogenesis of rheumatoid arthritis (RA). Clinical phase 2a testing has shown that treatment with an…
  • Abstract Number: 1059 • 2012 ACR/ARHP Annual Meeting

    Endogenous Complement Factor H Plays an Important Role in Controlling Immune Complex-Induced Inflammatory Arthritis

    Nirmal K. Banda1, Gaurav Mehta2, Viviana P. Ferreira3, Claudio Cortes3, Michael K. Pangburn4, William P. Arend2 and V. Michael Holers2, 1University of Colorado School of Medicine, Aurora, CO, 2Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 3Department of Medical Microbiology and Immunology, University of Toledo Health Science Campus, Toledo, OH, 4Department of Biochemistry, University of Texas Health Sciences Center, Tyler, TX

    Background/Purpose: The complement system, a major component of innate immunity, likely plays an important role in the pathogenesis of rheumatoid arthritis (RA).  Factor H (fH)…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology